98%
921
2 minutes
20
Musculoskeletal (MSK) disorders significantly contribute to global disability, especially in high-income countries. Yet, comprehensive studies on their epidemiological burden in the United States (US) are limited. Our study aims to fill this gap by characterizing the MSK disease burden in the US using Global Burden of Disease (GBD) data from 1990 to 2019. We conducted an ecological study using descriptive statistical analyses to examine age-standardized prevalence and disability-adjusted life years (DALY) rates of MSK disorders across different demographics and states. The study also assessed the impact of risk factors segmented by age and sex. From 1990 to 2019, the burden of MSK disorders in the US increased significantly. Low back pain was the most prevalent condition. Age-standardized prevalence and DALY rates increased by 6.7% and 17.6%, respectively. Gout and other MSK disorders saw the most significant rise in DALY rates. Females experienced higher rates than males, and there were notable geographic disparities, with the District of Columbia having the lowest and North Dakota and Iowa the highest DALY rates. Smoking, high BMI, and occupational risks emerged as primary risk factors. Our study highlights the escalating burden of MSK disorders in the US, revealing significant geographic and sex disparities. These findings highlight the urgent need for targeted health interventions, policy formulation, and public health initiatives focusing on lifestyle and workplace modifications. Region- and sex-specific strategies are crucial in effectively managing MSK conditions, considering the influence of various risk factors.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11594379 | PMC |
http://dx.doi.org/10.3390/jcm13226732 | DOI Listing |
Hand Ther
August 2025
Centre for Applied Health & Social Care Research, Sheffield Hallam University, UK.
Introduction: Non-traumatic wrist disorders (NTWD) are commonly encountered across care settings, but current patterns of care and clinicians beliefs about the care they provide remains unclear.
Objective: This study aimed to record management approaches to care for NTWD across clinical groups and care settings.
Methods: Ethical approval was sought for an online cross-sectional survey of clinicians [1 Jul - 1 Nov 2023], comprising 18 questions exploring profession, work setting, exposure to NTWD, alongside diagnostic and management confidence.
Prostate
September 2025
Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Background: Genomic instability is a key feature of cancer and plays a central role in tumor progression. One emerging metric for genomic instability is the fraction of genome altered (FGA), which quantifies the proportion of the genome affected by copy number alterations. Previous studies in various solid tumors have shown that high FGA is associated with aggressive disease and adverse clinical outcomes.
View Article and Find Full Text PDFPediatr Int
September 2025
Department of Pediatric Neurology, Uludağ University Faculty of Medicine, Bursa, Turkey.
Background: Musculoskeletal (MSK) pain is a prevalent chronic condition in children, adversely affecting their physical and emotional well-being. Parental health literacy (HL) is essential for managing children's health needs, yet its role in pediatric MSK pain remains largely unexplored. This study aims to assess HL levels of parents of children with MSK pain.
View Article and Find Full Text PDFBlood
August 2025
Memorial Sloan Kettering Cancer Center, New York, New York, United States.
Success of chimeric antigen receptor (CAR) T-cell therapy in lymphoid malignancies has not yet been recapitulated in acute myeloid leukemia (AML). We developed CAR T-cells targeting CD371 with a mutated CD28 costimulatory domain to limit T-cell exhaustion, and constitutive interleukin-18 secretion to enhance immune function (CD371/SAVVY/IL-18 CAR). We initiated a phase I trial (NCT06017258), successfully manufactured and administered CD371/SAVVY/IL-18 CAR T-cells in 5 patients with relapsed/refractory AML and observed expansion following a single infusion of 3x104 or 3x105 CAR T-cells/kg; three patients refractory to ≥5 lines of therapy and post-allogeneic transplant exhibited AML clearance and no evidence of graft-versus-host disease.
View Article and Find Full Text PDFWork
August 2025
Health through Physical Activity, Lifestyle and Sports Research Centre, Department of Human Biology, University of Cape Town, Cape Town, South Africa.
BackgroundThe COVID-19 pandemic posed unprecedented challenges to healthcare systems globally, particularly in Low- and Middle-Income Countries (LMICs), making it difficult to provide regular care to people with SCI.ObjectiveThis paper aims to present the perspectives of healthcare professionals from LMICs on the use of telehealth and/or telerehabilitation in SCI care during the COVID-19 pandemic, highlighting its scope, tools, barriers, facilitators and future implications.MethodsA qualitative approach was employed to gather insights from seven leading SCI healthcare professionals from Bangladesh, India, Nepal, Pakistan, and South Africa through structured interviews and an online questionnaire.
View Article and Find Full Text PDF